These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19351550)

  • 1. Octaarginine-liposomes as an effective vaccine carrier for mature dendritic cells.
    Park K
    J Control Release; 2009 May; 136(1):1. PubMed ID: 19351550
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes.
    Homhuan A; Kogure K; Nakamura T; Shastri N; Harashima H
    J Control Release; 2009 May; 136(1):79-85. PubMed ID: 19344678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes targeted to Fc receptors for antigen presentation by dendritic cells in vitro and in vivo.
    Serre K; Giraudo L; Leserman L; Machy P
    Methods Enzymol; 2003; 373():100-18. PubMed ID: 14714399
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity.
    Faham A; Bennett D; Altin JG
    Vaccine; 2009 Sep; 27(42):5846-54. PubMed ID: 19660589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cells.
    Reich M; Wieczerzak E; Jankowska E; Palesch D; Boehm BO; Burster T
    Immunol Lett; 2009 Apr; 123(2):155-9. PubMed ID: 19428564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
    Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P
    Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
    J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody.
    Abdel-Motal UM; Wigglesworth K; Galili U
    Vaccine; 2009 May; 27(23):3072-82. PubMed ID: 19428921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
    Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
    Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The good fat: a link between lipid bodies and antigen cross-presentation.
    Desjardins M
    Immunity; 2009 Aug; 31(2):176-8. PubMed ID: 19699167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
    O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
    Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Uncorking" of liposomes by matrix metalloproteinase-9.
    Sarkar NR; Rosendahl T; Krueger AB; Banerjee AL; Benton K; Mallik S; Srivastava DK
    Chem Commun (Camb); 2005 Feb; (8):999-1001. PubMed ID: 15719095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells.
    Senju S; Haruta M; Matsunaga Y; Fukushima S; Ikeda T; Takahashi K; Okita K; Yamanaka S; Nishimura Y
    Stem Cells; 2009 May; 27(5):1021-31. PubMed ID: 19415766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.
    Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P
    J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.
    Brgles M; Habjanec L; Halassy B; Tomasić J
    Vaccine; 2009 Sep; 27(40):5435-42. PubMed ID: 19632317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease.
    Shale M; Ghosh S
    Gut; 2009 Sep; 58(9):1291-9. PubMed ID: 19671557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro maturation and migration of immature dendritic cells after chemokine receptor 7 transfection.
    Xin HM; Peng YZ; Yuan ZQ; Guo H
    Can J Microbiol; 2009 Jul; 55(7):859-66. PubMed ID: 19767858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.